ANALYZING COPY NUMBER ALTERATIONS IN PREINVASIVE DISEASE OF HIGH-GRADE SEROUS OVARIAN CANCER TO BUILD THE BASIS FOR EARLY DETECTION

The General Hospital Corporation

Investigators